Skip to main content
. 2023 Mar 16;14(12):1089–1097. doi: 10.1111/1759-7714.14853

TABLE 5.

Expression of CALML5, CD5, c‐kit, and GLUT‐1 in thymic squamous cell carcinoma (TSQCC) and type B3 thymoma (THYM).

No. of positive cases (%)
Tumor type No. of patients CALML5 CD5 c‐kit GLUT‐1
TSQCC 26 19 (73.1) 18 (69.2) 24 (92.3) 26 (100.0)
THYM 38 2 (5.3) 1 (2.6) 2 (5.3) 15 (39.5)